Beam Therapeutics (BEAM) Shares Issued (2019 - 2026)

Beam Therapeutics (BEAM) has 8 years of Shares Issued data on file, last reported at $1.5 million in Q1 2026.

• Shares Issued for Q1 2026 came in at $1.5 million, up 0.6% year-over-year; the trailing twelve-month figure through Mar 2026 was $9000.0 (down 99.67% YoY), and the FY2024 annual result was $2.6 million, down 13.56% from the prior year.
• Shares Issued grew to $1.5 million in Q1 2026 per BEAM's latest filing, from -$2.9 million in the prior quarter.
• Over five years, Shares Issued peaked at $106.3 million in Q4 2022 and troughed at -$92.3 million in Q2 2023.
• A 5-year average of $7.7 million and a median of $1.4 million in 2025 frame the typical range for Shares Issued.
• The sharpest annual moves came in 2023 and 2025: Shares Issued jumped 6555.88% in 2023, then tumbled 288500.0% in 2025.
• A 5-year view of Shares Issued shows it stood at $106.3 million in 2022, then tumbled by 102.21% to -$2.4 million in 2023, then jumped by 99.96% to -$1000.0 in 2024, then plunged by 288500.0% to -$2.9 million in 2025, then soared by 152.32% to $1.5 million in 2026.
• Business Quant data shows BEAM's Shares Issued at $1.5 million in Q1 2026, -$2.9 million in Q4 2025, and $1.4 million in Q3 2025.